Q2 2023 Taysha Gene Therapies Inc Earnings Call Transcript
Good morning. Welcome to Taysha Gene Therapies Second Quarter 2023 Financial Results and Corporate Update Conference Call. (Operator Instructions) As a reminder, this webcast is being recorded today, August 14, 2020.
I will now turn the call over to Hayleigh Collins, Director, Head of Corporate Communications. Please go ahead.
Thank you. Good morning, and welcome to Taysha's second quarter 2023 financial results and corporate update conference call.
Earlier today, Taysha issued a press release announcing financial results for the second quarter of 2023. A copy of this press release is available on the company's website and through our SEC filings.
Joining me on today's call are Sean Nolan, Taysha's CEO; Sukumar Nagendran, President and Head of R&D; and Kamran Alam, Chief Financial Officer. (Operator Instructions)
Please note that on today's call, we will be making forward-looking statements, including statements relating to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |